Kronos Bio Inc reports results for the quarter ended in June - Earnings Summary

Kronos Bio

09/08/2023 01:36

* Kronos Bio Inc  KRON.OQ  reported a quarterly adjusted
loss
of 52 cents​​ per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for a loss
of 46 cents per share.
    * Revenue was $1.86 million​; analysts expected $1.67
million. 
    * Kronos Bio Inc's reported EPS for the quarter was a loss
of 52
cents​.
    * The mean earnings estimate of analysts had risen by
about 7.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Kronos Bio Inc shares had fallen by 2.9% this quarter and
gained 3.1% so far this year.
    * The company reported a quarterly loss of $29.74 million.
    * Wall Street's median 12-month price target for Kronos Bio
Inc is
$10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 12:36 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.46          -0.52          Missed
 Mar. 31 2023      -0.44          -0.46          Missed
 Dec. 31 2022      -0.59          -0.56          Beat
 Sep. 30 2022      -0.65          -0.57          Beat